New pill tested for Tough-to-Treat leukemias
Disease control
Terminated
This study is testing a new oral drug called CA-4948 (emavusertib) for adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or hasn't responded to prior treatments. The main goals are to find the safest and most effective dose an…
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC